J&J settles with West Virginia on opioid litigation for $99 million
(Reuters) — Johnson & Johnson said Monday it has agreed to pay $99 million to settle opioid-related claims by the state of West Virginia and its sub-divisions, removing the company from an ongoing trial that began earlier this month.
West Virginia is still pursuing claims against Teva Pharmaceuticals Industries Ltd. and AbbVie Inc.'s Allergan in the Kanawha County Circuit Court trial for allegedly fueling the addiction crisis in the state.
J&J did not admit liability or wrongdoing in the settlement, the company said.
J&J finalized a nationwide $5 billion opioid settlement in February, which largely resolved state and local government opioid lawsuits against the company.
West Virginia was one of five states that did not join the $5 billion settlement at that time. It would have received about $53 million if it had joined the agreement.
West Virginia has been hit particularly hard by the U.S. opioid crisis, which has caused 500,000 overdose deaths over the past two decades. In 2020, it had an overdose death rate of more than three times the national average, according to statistics from the U.S. Centers for Disease Control and Prevention.
Read Next
-
West Virginia says J&J, drugmakers created 'tsunami' of opioid addiction
(Reuters) -- West Virginia's attorney general on Monday urged a judge to hold Johnson & Johnson, Teva Pharmaceuticals Industries Ltd., and AbbVie Inc.'s Allergen liable for causing a "tsunami" of opioid addiction in the state.
Related Stories
-
West Virginia says J&J, drugmakers created 'tsunami' of opioid addiction
-
Trial opens in West Virginia lawsuit against opioid manufacturers
-
-
Walgreens fed opioid addiction, Florida says as trial starts
-
McKinsey breached firewall between opioid makers, regulators: NY Times
Most Read in Risk Management
-
2. Zurich North America names professional liability, cyber leader
-
6. Aon reports 5% revenue increase; looks to middle-market growth
